Articles by Sushil Abraham - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Sushil Abraham

Practical Considerations for Demonstrating Drug Substance Uniformity

The authors describe considerations and best practices for meeting drug substance uniformity.
Apr 1, 2011

The authors describe considerations and best practices for meeting drug substance uniformity.

Successful Technology Transfer, Process Validation, and Partnership with a CMO

The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.
Mar 2, 2011

The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.

ADVERTISEMENT

ADVERTISEMENT

Click here